Skip to main content
Home
  • en
  • fr
  • Profile
    • About DEINOVE
    • Board of Directors
    • Executive Committee
    • Founders
    • A word from the CEO
  • Antibiotics
    • About
    • Antimicrobial resistance
    • Portfolio
    • The AGIR program
    • Discovery platform
    • Partners
  • Bioactives
    • About
    • Biodiversity
    • Portfolio
    • Platform of Expertise
    • Partners
  • Investor room
    • Corporate governance
    • DEINOVE Shares
    • Financial Calendar
    • Documentation Center
    • Press releases
    • Investor relations
  • News & events
    • Press releases
    • Events
    • Press coverage
  • Careers
    • Join DEINOVE
    • Open positions
  1. Home
  2. News & events
  3. Press releases

Press releases

31.01.2019

Deinove is preparing initiation of Phase II for DNV3837 in Clostridium difficile infections, with a key partner

The test design has been improved for a better assessment of DNV3837 effectiveness in treating Clostridium difficile infections, This will...
10.01.2019

A new website to highlight DEINOVE’s disruptive innovation strategy

The new DEINOVE website displays an updated presentation of DEINOVE’s corporate activities and identity It illustrates the disruptive...
22.11.2018

Deinove will market a 2nd proprietary carotenoid-based cosmetic active ingredient in 2019

After launching Phyt-N-Resist® in 2018, Deinove is developing on its own a 2 nd innovative bio-based carotenoid for the cosmetics market...
21.11.2018

DEINOVE confirms its financing options by renewing its equity line

The equity line funding set up in December 2014 expired. It has enabled DEINOVE to raise €9.4 million net in a flexible, optimized manner...
24.10.2018

DEINOVE to collaborate with CALIBR to explore broadly the anti-infectious potentials of its bacterial collection

CALIBR is a division of the Scripps Research, a California non-profit corporation, dedicated to finding new treatments addressing unmet...
02.10.2018

Strategic partnership between DEINOVE and SOLVAY for the marketing of phytoene in North America and Asia

Solvay Novecare will market Phytoene as a cosmetic active ingredient in North America and Asia under the name ReGeN-oPhyt® This agreement...
28.09.2018

Deinove is the regional winner of the ‘PME Bougeons-nous’ awards in the ‘creative business’ category

The “PME Bougeons-nous” awards, organized by RMC, is the leading SME contest in France; DEINOVE was selected as the regional winner of the...
27.09.2018

2018 half-year consolidated results: strengthened financial situation, substantial progress in both areas of business

Cash position: +€9.9m at June 30, 2018 compared to +€4.9m at December 31, 2017 thanks to the reinforcement of shareholders' equity Half-...
13.09.2018

Strategic partnership between DEINOVE and UNIVAR for the distribution of Phyt-N-Resist® in the EMEA zone

UNIVAR will distribute the Phyt-N-Resist ® cosmetic active ingredient in the EMEA zone; UNIVAR is a world leader in the distribution of...
09.07.2018

Deinove awarded by the bioeconomy community

DEINOVE won the “Most Innovative Technology” award, with PHYT-N-RESIST ® , during the nnual meeting point for IAR cluster members. is the...
  • « first
  • ‹ previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »

News & events

  • Press releases
  • Events
    • Past events
  • Press coverage
  • Contact
  • Location
  • Legal Info
  • Site map
  • Privacy Policy

Profile

  • About DEINOVE
  • Board of Directors
  • Executive Committee
  • Founders
  • A word from the CEO

Antibiotics

  • About
  • Antimicrobial resistance
  • Portfolio
  • The AGIR program
  • Discovery platform
  • Partners

Bioactives

  • About
  • Biodiversity
  • Portfolio
  • Platform of Expertise
  • Partners

Investor room

  • Corporate governance
  • DEINOVE Shares
  • Financial Calendar
  • Documentation Center
  • Press releases
  • Investor relations

Careers

  • Join DEINOVE
  • Open positions

News & events

  • Press releases
  • Events
  • Press coverage

Downloads

  • Investor presentations
  • Analyst Coverage
  • Financial Reports

Follow us

Stay in touch

Subscribe to our newsletter

Contact us

ZAC Euromédecine II, Cap Sigma, 1682 Rue de la Valsière, 34790 Grabels, France

+33 (0)4 48 19 01 00

Home